MYC and neuroblastoma: In contrast to this observation, Devaiah and colleagues observed an increase in c-Myc half-life in MZ1-treated neuroblastoma cells, due to the loss of destabilizing phosphorylation on T58, whereas treatment with JQ1 did not affect c-Myc turnover [58].